BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8798655)

  • 21. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
    Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
    J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
    Weih F; Carrasco D; Bravo R
    Oncogene; 1994 Nov; 9(11):3289-97. PubMed ID: 7936653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells.
    Wissink S; van de Stolpe A; Caldenhoven E; Koenderman L; van der Saag PT
    Immunobiology; 1997 Dec; 198(1-3):50-64. PubMed ID: 9442377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
    Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
    Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell.
    De Bosscher K; Vanden Berghe W; Vermeulen L; Plaisance S; Boone E; Haegeman G
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3919-24. PubMed ID: 10760263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin-dependent E1A activity modulates NF-kappaB RelA-mediated repression of glucocorticoid receptor-dependent transcription.
    Burkhart BA; Hebbar PB; Trotter KW; Archer TK
    J Biol Chem; 2005 Feb; 280(8):6349-58. PubMed ID: 15556937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1.
    Raj GV; Safak M; MacDonald GH; Khalili K
    J Virol; 1996 Sep; 70(9):5944-53. PubMed ID: 8709216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation.
    Liden J; Delaunay F; Rafter I; Gustafsson J; Okret S
    J Biol Chem; 1997 Aug; 272(34):21467-72. PubMed ID: 9261164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3.
    Dai R; Phillips RA; Ahmed SA
    J Immunol; 2007 Aug; 179(3):1776-83. PubMed ID: 17641044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB.
    Ruan H; Pownall HJ; Lodish HF
    J Biol Chem; 2003 Jul; 278(30):28181-92. PubMed ID: 12732648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional activation of the chicken lysozyme gene by NF-kappa Bp65 (RelA) and c-Rel, but not by NF-kappa Bp50.
    Phi van L
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):39-44. PubMed ID: 8546707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of RelB in transgenic mice does not affect I kappa B alpha levels: differential regulation of RelA and RelB by the inhibitor protein.
    Weih F; Lira SA; Bravo R
    Oncogene; 1996 Jan; 12(2):445-9. PubMed ID: 8570223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
    Jang HD; Yoon K; Shin YJ; Kim J; Lee SY
    J Biol Chem; 2004 Jun; 279(23):24873-80. PubMed ID: 15140884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene.
    Sammons M; Wan SS; Vogel NL; Mientjes EJ; Grosveld G; Ashburner BP
    J Biol Chem; 2006 Sep; 281(37):26802-12. PubMed ID: 16829531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
    McKay LI; Cidlowski JA
    Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In adenovirus type 12 tumorigenic cells, major histocompatibility complex class I transcription shutoff is overcome by induction of NF-kappaB and relief of COUP-TFII repression.
    Hou S; Guan H; Ricciardi RP
    J Virol; 2002 Apr; 76(7):3212-20. PubMed ID: 11884545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SRY interacts with and negatively regulates androgen receptor transcriptional activity.
    Yuan X; Lu ML; Li T; Balk SP
    J Biol Chem; 2001 Dec; 276(49):46647-54. PubMed ID: 11585838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.
    Mishra A; Bharti AC; Varghese P; Saluja D; Das BC
    Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.